CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Director bought 100,000 shares at $0.79 ($79,180)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K/A Event Regulation FD disclosure
- 4/A Open-market buy Director bought 12,500 shares at $2.00 ($25,000)
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.08 ($41,500)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.00 ($4,000)
- 4 Open-market buy Director bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy Director bought 50,000 shares at $2.00 ($100,000)
- 4 Open-market buy Chief Executive Officer bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy Director bought 25,000 shares at $2.00 ($50,000)
- 4 Open-market buy See remarks bought 100,000 shares at $2.00 ($200,000)
Page 54 of 76 · 1,519 filings